NOVOSIS
Live / Applied — Non-final action mailed (as of 29 Nov 2025)
What this means for you
Not registered yet, but its 24 Jun 2025 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 99250754
- Mark type
- Stylized text
- Filed
- 24 Jun 2025
- Attorney of record
- Caroline E. Bryce
Goods and services
- Class 005 — Pharmaceuticals: Implants comprising living tissue; surgical transplants being living tissues; bone morphogenetic protein for use as a bone growth media; bone cement for surgical and orthopaedic purposes; bone growth media consisting of biological materials for medical purposes; bone fillers consisting of living materials; surgical implants comprised of living tissues; dental adhesives; bone cement for medical purposes; bone void fillers comprised of living tissues; human allogeneic tissue; medicinal preparation for preventing osteoporosis to facilitate bone growth; pharmaceutical preparations for the treatment of bone fractures to facilitate bone growth; syringes sold filled with pharmaceutical preparations to facilitate bone growth
- Class 010 — Medical apparatus: Medical apparatus and instruments to facilitate bone growth; medical bone graft materials, namely, synthetic bone grafts; implants being prostheses for use in bone grafting, namely, bone substitutes for surgical use; artificial bones for implantation; artificial bone parts to be implanted in natural bones; injection device for pharmaceuticals to facilitate bone growth; bone void fillers comprised of artificial materials; bone implants composed of artificial materials; surgical bone cementation tools and equipment; substitutes for bones, cartilage, ligaments and tendons; dental implants made of artificial materials; artificial bone growth media; prosthetic and filling materials, namely, putty for use in the replacement of bones
Owner
- CG Bio Co., Ltd., Seoul, KR
Prosecution history
- 26 Feb 2026 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
- 26 Feb 2026 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
- 29 Nov 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 29 Nov 2025 — NON-FINAL ACTION E-MAILED
- 29 Nov 2025 — NON-FINAL ACTION WRITTEN
- 13 Nov 2025 — ASSIGNED TO EXAMINER
- 31 Oct 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 24 Jun 2025 — APPLICATION FILING RECEIPT MAILED
- 24 Jun 2025 — NEW APPLICATION ENTERED